CB1-IN-3

CB1-IN-3 (Compound 6i) is a potent cannabinoid type 1 receptor (CB1) inhibitor. CB1-IN-3 is promising for research of obesity, inflammation, and neurological diseases[1].

Product Specifications

UNSPSC

12352005

Target

Cannabinoid Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Metabolic Disease; Inflammation/Immunology; Neurological Disease

Smiles

O=C(NC1=CC=CC(C(CN2C=CC=N2)=O)=C1)NC3=CC=C(C)C([N+]([O-])=O)=C3

Molecular Formula

C19H17N5O4

Molecular Weight

379.37

References & Citations

[1]Tsemperlidou E, et al. Synthesis of New N, N'-Diarylureas and Their Theoretical Study as Cannabinoid-1 Receptor Inhibitors. Chempluschem. 2025 Jun 13:e2500270.